Availability: | |
---|---|
Quantity: | |
Selumetinib is used to treat neurofibromatosis type 1 (NF1; a nervous system disorder that causes tumors to grow on nerves) in children 2 years of age and older who have plexiform neurofibromas (PN; soft tumors) that cannot be completely removed by surgery. Selumetinib is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that signals the tumors to grow. This helps to stop or slow tumor growth.
CAS:606143-52-6
Molecular Formula:C17H15BrClFN4O3
Qualifications:GMP Evaluate Report
File:MOA DMF
Standard:In house
Selumetinib is used to treat neurofibromatosis type 1 (NF1; a nervous system disorder that causes tumors to grow on nerves) in children 2 years of age and older who have plexiform neurofibromas (PN; soft tumors) that cannot be completely removed by surgery. Selumetinib is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that signals the tumors to grow. This helps to stop or slow tumor growth.
CAS:606143-52-6
Molecular Formula:C17H15BrClFN4O3
Qualifications:GMP Evaluate Report
File:MOA DMF
Standard:In house